- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04175795
Effectiveness of a Personalized Health Profile on Specificity of Self-Management Goals
Effectiveness of a Personalized Health Profile on Specificity of Self-Management Goals Among People Living With HIV in Canada: A Blinded Pragmatic Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Introduction: With a growing number of people living with chronic diseases, the need to empower people to self-manage their condition is rising. A key element in self-management is goal setting, however, it is not known to what extent people living with chronic conditions are capable of setting their own actionable health-related goals. One possible strategy to improve goal-setting skills is to provide people with specific information about their health profile to stimulate the setting of specific goals. This study contributes to the understanding of the specificity of patient-formulated self-management goals by testing the effectiveness of providing feedback using a personalized health outcome profile.
Objective: To estimate among people living with HIV, to what extent providing feedback on their health outcomes, compared to no feedback, will affect number and specificity of person-defined self-management goals.
Design: A blinded, stratified, randomized controlled trial design will be conducted targeting all participants in the BHN2 (Action for Positive Brain Health Now) cohort in Canada.
Methods: A personalized health outcome profile has been produced for each person enrolled in the BHN1 cohort (Positive Brain Health Now) at cohort entry and at the last recorded visit. The same profile will be developed for the participants who will enroll in the BHN2 as they go through their visits. The profile covers information on brain health outcomes, health and quality of life ratings, and lifestyle factors. Participants from the BHN1 who agreed to enroll in the BHN2 as well as the new participants will be contacted. The intervention group will receive their personal profile along with instructions on goal-setting and tips to improve brain health; the control group will receive only the goal-setting instructions and tips. Over 800 members of the BHN cohort have sufficient data to generate the profile and will be recruited into the study. Persons will be instructed to enter their goals on a specialized web-based goal setting platform within 2 weeks of receiving their profile. At the close of the two-week period, the control group will receive their profile. Text mining techniques will be used to extract information from the person-defined goals and the specificity of the goal will be scored based on word matches to a developed goal-setting lexical.
Expected Results: The expectation is that the intervention group will set more goals and have more words matching the developed lexical than the control group. The total number of words per person-goal will be calculated for each group and Poisson regression will be used to estimate the rate ratio and 95% confidence intervals and compare rate ratios between men and women using an interaction term.
Conclusion: The effect of providing outcome feedback on setting effective self-management goals will be tested in this study. The results will provide a thorough understanding of the quality of person-defined goals using text mining. Moreover, this study provides evidence necessary for future studies using text mining as an inexpensive and timely way for evaluation of textual information.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Maryam Mozafarinia, PhD student
- Telefonnummer: (438) 990-1805
- E-mail: maryam.mozafarinia@mail.mcgill.ca
Undersøgelse Kontakt Backup
- Navn: Dr. Nancy Mayo
- Telefonnummer: 32147 (514) 934-1934
- E-mail: nancy.mayo@mcgill.ca
Studiesteder
-
-
Quebec
-
Montreal, Quebec, Canada
- CHUM
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
This study is a sub-study under the BHN trial. Eligibility criteria for the main BHN trial includes:
Inclusion Criteria:
- adults age ≥ 35 who have been diagnosed as HIV positive for at least one year, - able to communicate adequately in French or English,
- and able to give an informed consent
Exclusion Criteria:
- dementia,
- life expectancy of <3 years or other,
- non-HIV-related neurological disorder,
- known active central nervous system opportunistic infection or hepatitis C requiring Interferon treatment,
- known Psychotic disorder,
- current (within the past 12 months) substance dependence or abuse.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Dashboard group
The intervention group will receive their personal profile via this e-mail along with instructions on goal-setting and tips to improve brain health.
|
The intervention of this study is grounded in the knowledge-to-action framework (Graham et al., 2006) and consists of providing feedback by sending participants their personalized health outcome profiles.
As mentioned above, the context of our study is the BHN cohort.
For all participants enrolled in the parent study, data on wide spectrum of health outcomes have been gathered.
As part of the knowledge translation plan, a personalized profile of specific modifiable health outcomes called as "My Personalized Brain Health Profile" has been created for each participant (Appendix B).
The profile covers information on brain health outcomes, health and quality of life ratings, and lifestyle factors.
|
Ingen indgriben: No Dashboard group
The control group will receive only the goal-setting instructions and tips.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Goal specificity
Tidsramme: "4 weeks" in total for each participant
|
The main outcome in this study is the specificity of self-management goals.
For goal specificity, text mining techniques will be used.
This outcome will be reported as a time-independent discrete variable - number of specific words (matched to a developed lexical) per person-goals.
|
"4 weeks" in total for each participant
|
Number of self-management goals
Tidsramme: "4 weeks" in total for each participant
|
For this outcome number of goals per person as well as total number of goals per group will be reported.
|
"4 weeks" in total for each participant
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ABHN_Goals
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kronisk sygdom
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRekrutteringRefractory Chronic Graft Versus Host Disease (cGVHD)Belgien
-
Novartis PharmaceuticalsLedigPrimær myelofibrose (PMF) | Polycytæmi Vera (PV) | Post polycytæmi myelofibrose (PPV MF) | Trombocytæmi myelofibrose (PET-MF) | Alvorlig/meget svær COVID-19 sygdom | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)
Kliniske forsøg med My Personal Brain Health Dashboard
-
BaycrestAfsluttetDemens | Mild kognitiv svækkelse | Forebyggelse af demens | Subjektiv kognitiv svækkelse | Præ-demensCanada
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttetDiabetes mellitus, type 2Forenede Stater
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttet
-
Massachusetts General HospitalAfsluttetForhøjet blodtryk | Diabetes | BrystkræftForenede Stater
-
Indiana UniversityNational Cancer Institute (NCI)RekrutteringKræftForenede Stater
-
Yale UniversityNational Library of Medicine (NLM)Ikke rekrutterer endnuPersonlige helbredsoplysninger | Fængslede individerForenede Stater
-
Posit Science CorporationYMCA of San FranciscoRekrutteringDemens | Alzheimers sygdomForenede Stater
-
BaycrestAktiv, ikke rekrutterendeKognitiv forandring | Mild kognitiv svækkelse | Forebyggelse af demens | Subjektiv kognitiv svækkelseCanada
-
Sunnaas Rehabilitation HospitalUniversity of Oslo; Oslo University Hospital; University of GlasgowAfsluttet
-
Lawson Health Research InstituteRekruttering